Association of the C-reactive protein-triglyceride glucose index with microvascular obstruction and long-term prognosis in patients with acute myocardial infarction: a CMR-based study
Frontiers in Endocrinology · 15.07.2026 · 17
DOI: 10.3389/fendo.2026.1889147 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Frontiers in Endocrinology, online erschienen am 15.07.2026. Verfasst von Lei Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. Hauptthemen laut MEDLINE: Myocardial Infarction, Microvessels, C-Reactive Protein, Triglycerides. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The clinical benefits of percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) are frequently compromised by the occurrence of microvascular obstruction (MVO). The C-reactive protein-triglyceride glucose index (CTI) is a novel biomarker integrating systemic inflammation and insulin resistance. We aimed to evaluate the association between CTI and MVO, as well as its prognostic value for long-term outcomes in AMI patients.
Methods
This study included patients with AMI who underwent successful primary PCI and subsequent cardiac magnetic resonance (CMR). MVO and cardiac function were assessed by CMR. The primary endpoint was the occurrence of MVO, and the secondary endpoint was the incidence of major adverse cardiovascular events (MACE).
Results
A total of 967 patients were ultimately included, comprising 255 with diabetes mellitus and 712 without diabetes; 476 patients developed CMR-defined MVO. Higher baseline CTI levels were significantly and independently associated with an increased risk of MVO (OR = 1.33, 95% CI: 1.13–1.56, P = 0.001). A linear dose-response relationship was observed between CTI and MVO risk (P for overall < 0.05, P for nonlinear > 0.05). During a median follow-up of 43 months, higher CTI levels were associated with an increased risk of long-term MACE in the overall population and the non-diabetic subgroup, whereas this association was attenuated in patients with diabetes mellitus.
Conclusions
CTI is independently associated with MVO after PCI in AMI patients and shows modest prognostic value for long-term MACE, particularly in patients without diabetes. As a clinically accessible tool, CTI may facilitate early risk stratification and individualized microvascular protection strategies following PCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
- National Heart Centre Singapore, Duke - NUS Medical School, Singapore, Singapore.
- Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Zitieren
APA
Chen, L., Zong, D., Lu, P., Oketunbi, T. J., Du, M., Liu, D., Qi, X., Che, W., Lu, Y., & Chen, W. (2026). Association of the C-reactive protein-triglyceride glucose index with microvascular obstruction and long-term prognosis in patients with acute myocardial infarction: a CMR-based study. Frontiers in Endocrinology, 17. https://doi.org/10.3389/fendo.2026.1889147
Vancouver
Chen L, Zong D, Lu P, Oketunbi TJ, Du M, Liu D, et al. Association of the C-reactive protein-triglyceride glucose index with microvascular obstruction and long-term prognosis in patients with acute myocardial infarction: a CMR-based study. Frontiers in Endocrinology. 2026;17. doi:10.3389/fendo.2026.1889147
BibTeX
@article{Chen2026,
author = {Chen, Lei and Zong, Dexiang and Lu, Peng and Oketunbi, Temilola J and Du, Mingchang and Liu, Donglin and Qi, Xueyuan and Che, Wenliang and Lu, Yuan and Chen, Wensu},
title = {Association of the C-reactive protein-triglyceride glucose index with microvascular obstruction and long-term prognosis in patients with acute myocardial infarction: a CMR-based study},
journal = {Frontiers in Endocrinology},
year = {2026},
volume = {17},
doi = {10.3389/fendo.2026.1889147}
}
EUVIMED